Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in acadia pharmaceuticals inc. of class action lawsuit and upcoming deadline - acad

New york, april 26, 2021 /prnewswire/ -- pomerantz llp announces that a class action lawsuit has been filed against acadia pharmaceuticals inc. ("acadia" or the "company") (nasdaq: acad) and certain of its officers. the class action, filed in the united states district court for the southern district of california, and docketed under 21-cv-00762, is on behalf of a class consisting of all persons and entities other than defendants that purchased or otherwise acquired acadia securities between june 15, 2020 and april 4, 2021, both dates inclusive (the "class period"), seeking to recover damages caused by defendants' violations of the federal securities laws and to pursue remedies under sections 10(b) and 20(a) of the securities exchange act of 1934 (the "exchange act") and rule 10b-5 promulgated thereunder, against the company and certain of its top officials.
ACAD Ratings Summary
ACAD Quant Ranking